CMC Acquires Former ICOS Biologics Operation in Bothell, Washington State, USA
CMC Biopharmaceuticals to purchase facility from Lilly; will retain existing employees
05-Dec-2007 -
CMC Biopharmaceuticals A/S (CMC) announced that it has reached an agreement to buy the biologics development and manufacturing operation that Eli Lilly and Company acquired when it purchased ICOS Corporation in January 2007. CMC, a Copenhagen based leading provider of contract biomanufacturing ...
biologics
biopharmaceuticals
clinical trials
+4